Case Studies Enhancing Research Productivity by 30%

Edit This Case Study Record

	Enhancing Research Productivity by 30%

Enhancing Research Productivity by 30%

Technology Category	Platform as a Service (PaaS) - Data Management Platforms
Applicable Industries	Pharmaceuticals Healthcare & Hospitals
Applicable Functions	Product Research & Development
Use Cases	Predictive Quality Analytics
Services	Cloud Planning, Design & Implementation Services
Challenge	Arcturus Therapeutics, a leader in RNA medicines, faced several challenges in their research process. The lack of standardized molecular design tools hindered their ability to collaborate effectively. Their legacy Electronic Lab Notebook (ELN) was cumbersome and led to low usage among scientists. It took an average of 10 days for experimental data to be entered into the system, if at all. Additionally, the absence of a standard data store and sequence repository scattered data and prevented the capture of institutional knowledge. Read More
About Customer	Arcturus Therapeutics is an industry leader in the development of RNA medicines. The company's mission is to leverage its versatile, breakthrough RNA platform to create novel therapies for rare diseases that currently lack adequate treatments. Arcturus collaborates with Janssen Pharmaceuticals and Ultragenyx Pharmaceutical, demonstrating its significant presence and influence in the pharmaceutical industry. Read More
Solution	Arcturus Therapeutics implemented Benchling's all-in-one, cloud-based suite to address their challenges. This suite allowed Arcturus scientists to design sequences together and share plasmids and annotations, enhancing collaboration. The Benchling Lab Notebook, with its rich protocol repository and direct Molecular Biology integration, was adopted by 90% of the users, a significant increase from the 20-30% user adoption of the legacy ELN. The time to data entry was reduced from 10 days to 1 day. Benchling became the central source of truth for the organization, enabling scientists to quickly locate data and reallocate more than 30% of their day-to-day work towards science, rather than note-taking and searching data. Read More Log in to view content
Contents

Technology Category

Platform as a Service (PaaS) - Data Management Platforms

Applicable Industries

Pharmaceuticals

Healthcare & Hospitals

Applicable Functions

Product Research & Development

Use Cases

Predictive Quality Analytics

Services

Cloud Planning, Design & Implementation Services

Challenge

Arcturus Therapeutics, a leader in RNA medicines, faced several challenges in their research process. The lack of standardized molecular design tools hindered their ability to collaborate effectively. Their legacy Electronic Lab Notebook (ELN) was cumbersome and led to low usage among scientists. It took an average of 10 days for experimental data to be entered into the system, if at all. Additionally, the absence of a standard data store and sequence repository scattered data and prevented the capture of institutional knowledge.

About Customer

Arcturus Therapeutics is an industry leader in the development of RNA medicines. The company's mission is to leverage its versatile, breakthrough RNA platform to create novel therapies for rare diseases that currently lack adequate treatments. Arcturus collaborates with Janssen Pharmaceuticals and Ultragenyx Pharmaceutical, demonstrating its significant presence and influence in the pharmaceutical industry.

Solution

Arcturus Therapeutics implemented Benchling's all-in-one, cloud-based suite to address their challenges. This suite allowed Arcturus scientists to design sequences together and share plasmids and annotations, enhancing collaboration. The Benchling Lab Notebook, with its rich protocol repository and direct Molecular Biology integration, was adopted by 90% of the users, a significant increase from the 20-30% user adoption of the legacy ELN. The time to data entry was reduced from 10 days to 1 day. Benchling became the central source of truth for the organization, enabling scientists to quickly locate data and reallocate more than 30% of their day-to-day work towards science, rather than note-taking and searching data.

Impact #1	Arcturus transitioned from a legacy ELN with 20-30% user adoption, to 90% adoption with the Benchling Lab Notebook.
Impact #2	With its rich protocol repository and direct Molecular Biology integration, Arcturus uses the Lab Notebook as an active tool in research, not only as a system of record after-the-fact.
Impact #3	Time to data entry reduced from 10 days to 1 day.

Impact #1

Arcturus transitioned from a legacy ELN with 20-30% user adoption, to 90% adoption with the Benchling Lab Notebook.

Impact #2

With its rich protocol repository and direct Molecular Biology integration, Arcturus uses the Lab Notebook as an active tool in research, not only as a system of record after-the-fact.

Impact #3

Time to data entry reduced from 10 days to 1 day.

Benefit #1	90% adoption of the Benchling Lab Notebook.
Benefit #2	Time to data entry reduced from 10 days to 1 day.
Benefit #3	Scientists reallocated more than 30% of their day-to-day work towards science.

Benefit #1

90% adoption of the Benchling Lab Notebook.

Benefit #2

Time to data entry reduced from 10 days to 1 day.

Benefit #3

Scientists reallocated more than 30% of their day-to-day work towards science.

Download PDF Version

Overview

Enhancing Research Productivity by 30%

Operational Impact

Quantitative Benefit